Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
4(67%)
Results Posted
200%(2 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_1
1
17%
Ph phase_2
1
17%
Ph phase_4
3
50%
Ph not_applicable
1
17%

Phase Distribution

1

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 4Post-market surveillance
3(50.0%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

6

all time

Status Distribution
Active(4)
Completed(1)
Terminated(1)

Detailed Status

Recruiting4
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
4
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 43 (50.0%)
N/A1 (16.7%)

Trials by Status

recruiting467%
completed117%
terminated117%

Recent Activity

4 active trials
Showing 5 of 6
recruitingphase_2

Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease

NCT05599347
terminatedphase_4

Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age

NCT05345457
recruitingnot_applicable

Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks

NCT05847322
recruitingphase_1

Azithromycin Before Induction

NCT06543290
completedphase_4

Individualizing Treatment for Asthma in Primary Care

NCT06272370
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05599347Phase 2

Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease

Recruiting
NCT05345457Phase 4

Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age

Terminated
NCT05847322Not Applicable

Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks

Recruiting
NCT06543290Phase 1

Azithromycin Before Induction

Recruiting
NCT06272370Phase 4

Individualizing Treatment for Asthma in Primary Care

Completed
NCT05772013Phase 4

Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations

Recruiting

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6